• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.65%

    TG Therapeutics, Inc. (TGTX)

    -NasdaqCM
    7.73 Up 0.51(7.06%) May 27, 4:00PM EDT
    Prev Close:7.22
    Open:7.85
    Bid:7.65 x 200
    Ask:10.00 x 800
    1y Target Est:25.14
    Beta:1.46657
    Earnings Date:Aug 8 - Aug 12 (Est.)
    Day's Range:7.41 - 7.86
    52wk Range:6.95 - 19.05
    Volume:843,587
    Avg Vol (3m):359,758
    Market Cap:420.04M
    P/E (ttm):N/A
    EPS (ttm):-1.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TGTX

    Comparison

    Symbol% ChgMkt Cap
    TGTXUp 7.06%420.04M
    BIIBUp 0.28%61.95B
    CELGUp 0.61%82.44B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2,562.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.15
    Quarterly EPS Est (Jun-16) :-0.29
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback